Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

3rd Annual Stability Testing Conference

Next-Gen Sequencing Trends 2009

Competitor Analysis: c-MET/HGF Inhibitors

The Japanese Pharmaceutical Market 2008-2023

New Products

Japanese Pharmaceutical Market 2009-2024

3rd Annual Lyophilisation Conference

The Global Bioinformatics Market: Market size, forecasts and company profiles

Pharmaceutical Mergers and Acquisitions (PH133)

Pharmaceutical Speaker Programs (PH134) Measuring ROI and Communicating Value

Strategic Clinical Sourcing (PH125)) Managing Costs and CROs

The Global Analgesics Market 2009-2024

Competitor Analysis: Coagulation Factors

Competitor Analysis: PDGF-R Agonists and Antagonists

World Market for Addiction Disorders, 2009-2016

BioPortfolio | Kalorama Reports | Medical Imaging Markets Volume V Molecular Imaging

Medical Imaging Markets Volume V Molecular Imaging

Molecular imaging maps the locations of specific molecules and biomaterials within living tissue. As such, it has the potential to diagnose a disease, to monitor the course of that disease, and possibly facilitate treatment. Molecular imaging has developed into a promising new strategy for the diagnosis, evaluation and treatment of disease. The final volume in Kalorama's Medical Imaging Markets series: Medical Imaging Markets, Volume V, Molecular Imaging offers complete market coverage of world markets for molecular imaging products for the following technologies:

PET

SPECT-Gamma Camera Systems

MRI

Ultrasound

Fusion Imaging

Optical Imaging

Interest in and use of the technology has exploded in recent years, thanks to advances in cell biology, biochemical agents, and computer analysis, and serious market watchers in medical imaging industries, as well as those serving or investing in medical imaging companies, will want to keep abreast of this new market. As part of its comprehensive coverage, Medical Imaging Markets, Volume V, Molecular Imaging includes:

Complete Overview and Explanation of modalities and key applications

Over 35 Figures and Tables to make market data accessible to users.

Review of Imaging Agents in Clinical Trials, or that are recently introduced.

Market Size and Forecasts are developed through 2011.

Profiles of Top Competitors in the industry including: including Gamma Medica, GE Healthcare, Hiatchi, OptoSonics, Philips, Siemens and Toshiba, among others.

Kalorama looks at the technologies currently used in molecular imaging but also examines novel research areas, such as:

PET Targets Alzheimer’s Disease

Rubidium-based PET

PET Diagnoses Pancreas Defects

Hyper-Cest MRI

Molecular Breast Imaging

Drug Abuse

Radiotracers and Drug Addiction

Whole-Body PET

PET/CT for Ovarian Cancer

SPECT for Lower Back Pain

Contrast-Enhanced Ultrasound

As part of Kalorama's trusted information-gathering process, the information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence with medical imaging company executives were the primary method of gathering information and developing forecasts.

May 1, 2007

136 Pages

PDF Format
Table of Contents
Price: $2,995.00 / €2,003.66

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions